Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaPep277 Long-Term Safety and Efficacy Extension in Type 1 Diabetes
NCT01898286Phase 3Terminated
- Sponsor
- Andromeda Biotech Ltd.
- Start
- Oct 2013
- Primary completion
- Sep 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diapep277 in type 1 diabetes mellitus (T1D), sponsored by Andromeda Biotech Ltd.. Started Oct 2013; status: terminated.
02
Drugs
diapep277
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01898286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898286.